logo
logo
Sign in

Propofol is fastest growing segment fueling the growth of General Anesthesia Drugs Market

avatar
Niranjan Mardakar
Propofol is fastest growing segment fueling the growth of General Anesthesia Drugs Market

The global General Anesthesia Drugs Market is estimated to be valued at US$ 4.95 Bn in 2023 and is expected to exhibit a CAGR of 4.1% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.


Market Overview:

General anesthesia drugs are administered during surgical procedures to induce unconsciousness, relieve pain, and provide muscle relaxation. These medications help enable complex medical and dental procedures to be performed safely and effectively on patients.


Market key trends:

One of the key trends in the general anesthesia drugs market is the rising demand for short-acting anesthetics. Short-acting anesthetics allow for faster recovery and enable ambulatory surgeries to be performed on an outpatient basis. They reduce the hospital stay duration for patients and lower healthcare costs. These drugs are preferred for minor surgical procedures like dental or cataract surgeries. Their adoption is growing significantly owing to increasing preference for minimally invasive procedures.

Segment Analysis


The general anesthesia drugs market is segmented into intravenous and inhalational anesthetics. The inhalational anesthetic segment dominated the market in 2022 due to inhaled anesthetics being preferred for general anesthesia. Inhaled anesthetics provide quick anesthesia induction and recovery compared to intravenous anesthetics.


Key Takeaways


The Global General Anesthesia Drugs Market Size is expected to witness high growth, exhibiting CAGR of 4.1% over the forecast period, due to increasing number of surgical procedures worldwide.


Regional analysis


North America dominated the general anesthesia drugs market in 2022 and is expected to continue its dominance over the forecast period. This is attributed to rising geriatric population, increasing prevalence of chronic diseases, and increasing number of surgical procedures in the US and Canada.


Key players


Key players operating in the general anesthesia drugs market are Baxter Healthcare, Dr. Reddy's Laboratories , Novartis International AG, Hospira, Maruishi, Hengrui, Lunan, Fresenius Kabi, Pfizer Inc., Hikma Pharmaceuticals, Sagent Pharmaceuticals, Teva Pharmaceuticals, Par Pharmaceutical, Viatris Inc., AbbVie, Piramal Critical Care, Aspen Global Incorporated, B. Braun SE, Abbott and Cosmo pharmaceuticals.


The global general anesthesia drugs market size is expected to reach US$ 4.95 Bn in 2023.

Read Our More Blogs : https://www.rapidwebwire.com/general-anesthesia-drugs-market-size-share-analysis-2023-2030/

collect
0
avatar
Niranjan Mardakar
guide
Zupyak is the world’s largest content marketing community, with over 400 000 members and 3 million articles. Explore and get your content discovered.
Read more